Cutting edge: Transplantation tolerance through enhanced CTLA-4 expression

被引:65
作者
Ariyan, C
Salvalaggio, P
Fecteau, S
Deng, SY
Rogozinski, L
Mandelbrot, D
Sharpe, A
Sayegh, MH
Basadonna, GP
Rothstein, DM
机构
[1] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA
[3] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA
[4] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA 01655 USA
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.171.11.5673
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Knockout and blocking studies have shown a critical role for CTLA-4 in peripheral tolerance, however, it is unknown whether augmenting CTLA-4 expression actually promotes tolerance. Here we demonstrate a specific and requisite role for CTLA-4 and its up-regulation in tolerance through anti-CD45RB. First, long-term murine islet allograft survival induced by anti-CD45RB is prevented by CTLA44g, which interferes with B7.-CTLA-4 interactions. Second, anti-CD45RB is ineffective in recipients lacking ng LA-4,B7-1, and B7-2. Incontrast, CTLA4-Ig, which targets B17 on allogeneic cells, promotes long-term engraftment in these mice. Moreover, anti-CD45Rb was effective in X-deficient controls expressing CTLA-4. Finally, in wildtype mice, CTLA-4 expression returned to baseline 17 days after receiving anti-CD45RB, and was refractory to further increase. Transplantation and anti-CD45RB therapy at this time could neither augment CTLA-4 nor prolong engraftment, These data demonstrate a specific role for CTLA-4 in anti-CD45RB-mediated tolerance and indicate that CTLA-4 up-regulation can directly promote allograft survival.
引用
收藏
页码:5673 / 5677
页数:5
相关论文
共 23 条
  • [11] Judge TA, 1999, J IMMUNOL, V162, P1947
  • [12] Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
    Larsen, CP
    Elwood, ET
    Alexander, DZ
    Ritchie, SC
    Hendrix, R
    TuckerBurden, C
    Cho, HR
    Aruffo, A
    Hollenbaugh, D
    Linsley, PS
    Winn, KJ
    Pearson, TC
    [J]. NATURE, 1996, 381 (6581) : 434 - 438
  • [13] Prevention and reversal of renal allograft rejection by antibody against CD45RB
    Lazarovits, AI
    Poppema, S
    Zhang, Z
    Khandaker, M
    LeFeuvre, CE
    Singhal, SK
    Garcia, BM
    Ogasa, N
    Jevnikar, AM
    White, MJ
    Singh, G
    Stiller, CR
    Zhong, RZ
    [J]. NATURE, 1996, 380 (6576) : 717 - 720
  • [14] Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
    Li, YS
    Li, XC
    Zheng, XX
    Wells, AD
    Turka, LA
    Strom, TB
    [J]. NATURE MEDICINE, 1999, 5 (11) : 1298 - 1302
  • [15] Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28
    Lin, H
    Rathmell, JC
    Gray, GS
    Thompson, CB
    Leiden, JM
    Alegre, ML
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) : 199 - 204
  • [16] B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)
    Mandelbrot, DA
    McAdam, AJ
    Sharpe, AH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 435 - 440
  • [17] Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function
    Martin, M
    Schneider, H
    Azouz, A
    Rudd, CE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (11) : 1675 - 1681
  • [18] Metz DP, 1998, J IMMUNOL, V161, P5855
  • [19] Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models
    Rothstein, DM
    Livak, MFA
    Kishimoto, K
    Ariyan, C
    Qian, HY
    Fecteau, S
    Sho, M
    Deng, SY
    Zheng, XX
    Sayegh, MH
    Basadonna, GP
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 322 - 329
  • [20] Islet filtration: A simple and rapid new purification procedure that avoids Ficoll and improves islet mass and function
    Salvalaggio, PRO
    Deng, SY
    Ariyan, CE
    Millet, I
    Zawalich, WS
    Basadonna, GP
    Rothstein, DM
    [J]. TRANSPLANTATION, 2002, 74 (06) : 877 - 879